| Myelodysplastic Syndrome altered in cohorts of …ALTERED_INderived27 of 27show fewer |
|---|
| ← altered in cohorts of | DNMT3A 853 / 4,231 cases (20 %) · ssm · mds_mskcc_2020 · largest of 2 cohorts | — | — | Myelodysplastic Syndrome | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TET2 683 / 4,231 cases (16 %) · ssm · mds_mskcc_2020 · largest of 2 cohorts | — | — | Myelodysplastic Syndrome | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NPM1 674 / 4,231 cases (16 %) · ssm · mds_mskcc_2020 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NRAS 492 / 4,231 cases (12 %) · ssm · mds_mskcc_2020 · largest of 2 cohorts | — | — | Myelodysplastic Syndrome | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FLT3 475 / 4,231 cases (11 %) · ssm · mds_mskcc_2020 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ASXL1 434 / 4,231 cases (10 %) · ssm · mds_mskcc_2020 · largest of 2 cohorts | — | — | Myelodysplastic Syndrome | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SRSF2 415 / 4,231 cases (9.8 %) · ssm · mds_mskcc_2020 · largest of 2 cohorts | — | — | Myelodysplastic Syndrome | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RUNX1 408 / 4,231 cases (9.6 %) · ssm · mds_mskcc_2020 · largest of 2 cohorts | — | — | Myelodysplastic Syndrome | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TP53 399 / 4,231 cases (9.4 %) · ssm · mds_mskcc_2020 · largest of 2 cohorts | — | — | Myelodysplastic Syndrome | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | STAG2 312 / 3,323 cases (9.4 %) · ssm · mds_iwg_2022 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SF3B1 378 / 4,231 cases (8.9 %) · ssm · mds_mskcc_2020 · largest of 2 cohorts | — | — | Myelodysplastic Syndrome | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | U2AF1 289 / 3,323 cases (8.7 %) · ssm · mds_iwg_2022 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | IDH2 359 / 4,231 cases (8.5 %) · ssm · mds_mskcc_2020 · largest of 2 cohorts | — | — | Myelodysplastic Syndrome | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | JAK2 336 / 4,231 cases (7.9 %) · ssm · mds_mskcc_2020 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EZH2 243 / 3,323 cases (7.3 %) · ssm · mds_iwg_2022 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2D 224 / 3,323 cases (6.7 %) · ssm · mds_iwg_2022 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC4 69 / 1,026 cases (6.7 %) · ssm · mds_mskcc_2020 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BCOR 220 / 3,323 cases (6.6 %) · ssm · mds_iwg_2022 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | IDH1 263 / 4,231 cases (6.2 %) · ssm · mds_mskcc_2020 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZRSR2 201 / 3,323 cases (6.0 %) · ssm · mds_iwg_2022 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CBL 200 / 3,323 cases (6.0 %) · ssm · mds_iwg_2022 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CUX1 192 / 3,323 cases (5.8 %) · ssm · mds_iwg_2022 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NBPF10 59 / 1,026 cases (5.8 %) · ssm · mds_mskcc_2020 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NF1 188 / 3,323 cases (5.7 %) · ssm · mds_iwg_2022 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SETBP1 188 / 3,323 cases (5.7 %) · ssm · mds_iwg_2022 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPN11 217 / 4,231 cases (5.1 %) · ssm · mds_mskcc_2020 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2C 168 / 3,323 cases (5.1 %) · ssm · mds_iwg_2022 | — | — | Myelodysplastic Syndrome | 1 | Observed | cbioportal | graph → |